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Abstract. To characterize the role of the endosome in 
the degradation of insulin in liver, we employed a cell- 
free system in which the degradation of internalized 
t25I-insulin within isolated intact endosomes was evalu- 
ated.  Incubation of endosomes containing  internalized 
~2sI-insulin in the cell-free system resulted in a  rapid 
generation of TCA soluble radiolabeled products (t,h, 6 
min).  Sephadex G-50 chromatography of radioactivity 
extracted from endosomes during the incubation 
showed a  time dependent increase in material eluting 
as radioiodotyrosine.  The apparent  V~x of the insulin 
degrading activity was 4 ng insulin degraded.min-l.mg 
cell fraction protein  -~ and the apparent Km was 60 ng 
insulin.mg  cell fraction protein  -t. The endosomal pro- 
tease(s) was insulin-specific since neither internalized 
~25I-epidermal growth factor (EGF) nor  ~25I-prolactin 
was degraded within  isolated endosomes as assessed 
by TCA precipitation  and Sephadex G-50 chromatogra- 
phy.  Significant inhibition  of degradation was observed 
after inclusion of p-chloromercuribenzoic acid 
(PCMB),  1,10-phenanthroline,  bacitracin,  or 0.1%  Tri- 
ton X-100  into the system. Maximal  insulin degrada- 
tion required the addition of ATP to the cell-free sys- 
tem that resulted in acidification as measured by 
acridine orange accumulation.  Endosomal insulin 
degradation was inhibited markedly in the presence of 
pH dissipating agents such as nigericin,  monensin,  and 
chloroquine or the proton translocase inhibitors 
N-ethylmaleimide (NEM) and dicyclohexylcarl~odii- 
mide (DCCD).  Polyethylene glycol (PEG) precipita- 
tion of insulin-receptor complexes revealed that en- 
dosomal degradation augmented the dissociation of 
insulin from its receptor and that dissociated insulin 
was serving as substrate to the endosomal protease(s). 
The results suggest that as insulin  is internalized  it 
rapidly but incompletely dissociates from its receptor. 
Dissociated insulin  is then degraded by an insulin 
specific protease(s) leading to further dissociation and 
degradation. 
T 
HE intracellular  site of insulin degradation  and its rela- 
tionship  to insulin  action within  target organs  is un- 
clear  (29,  30).  Following  the  binding  of insulin  to 
specific receptors located on the surface of target cells, insu- 
lin  is  internalized  along  with  its receptor into a heteroge- 
neous series of endocytic  elements  collectively termed the 
endosomal apparatus (10, 13, 14). Several studies (12, 40, 53, 
56) have indicated that internalized  insulin is degraded with- 
in these endosomal components.  To characterize  this process 
directly,  we have studied insulin  degradation  within  intact 
endosomes isolated from liver parenchyma in a cell-free sys- 
tem. Here we show that endosomal degradation was selective 
in that internalized  insulin was degraded but not epidermal 
growth factor (EGF) t or prolactin.  Insulin degradation  was 
regulated by endosomal acidification that led to both the dis- 
sociation of insulin  from its  receptor as well  as maximal 
degrading  activity by an insulin-specific  protease(s). 
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1.  Abbreviations  used in  this paper:  EGF,  epidermal growth factor; GE, 
Golgi-endosome; PCMB, p-chloromercuribenzoic acid; PEG, polyethylene 
glycol. 
Materials and Methods 
Ligand Radioiodination, Protein Determination, 
and Materials 
Porcine insulin (26.8 IU-mg  -I, gift of Eli Lilly,  Indianapolis, IN), mouse 
EGF  (Collaborative Research, Inc.,  Waltham,  MA) and ovine prolactin 
(30.5 IU.mg  -t, gift of National Hormone and Pituitary Program, National 
Institutes of Health, Bethesda, MD) were radioiodinated by the chloramine 
T method (43) with modifications as described previously (55) to specific 
activities of 102-174 #Ci-p.g  -I , 191-251 ttCi.v.g -l, and 100-148/~Ci./xg -I , 
respectively. Protein in subcellular fractions was determined by the method 
of Bradford (17). All chemicals were of analytical grade and purchased from 
Sigma Chemical Co. (St. Louis, MO), Fisher Scientific Canada (Montreal, 
Canada), or Anachemia Inc. (Montreal, Canada). 
Preparation of the Golgi-Endosome (GE) Fraction 
Containing Internalized 12~l-lnsulin, 12q-EGF, 
and 12q-Prolactin 
AGE  fraction containing internalized ligands was prepared as described 
previously (9, 46) with minor modifications. Female Sprague Dawley rats 
(140-180  g) that had been fasted 14-16 h were injected with 140-180  ng of 
either J251-insulin, 1251-EGF, or 125I-prolactin via the hepatic portal vein. 5 
rain after injection animals were sacrificed by decapitation, allowed to ex- 
sanguinate via the cervical wound, and the livers were removed rapidly and 
minced in ice cold 0.25 M sucrose in HKM buffer (20 mM Hepes, pH 7.4, 
25 mM KCI,  10 mM MgCI2).  Livers were homogenized with 4-5 strokes 
of a motor driven Teflon pestle (Thomas Scientific, Swedesboro, N  J) (2,300 
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mogenate was adjusted to 1.1 M sucrose in HKM buffer and samples subse- 
quently overlaid with a continuous density gradient ranging from 0.25 M 
to 1.07 M sucrose in HKM and centrifuged at 200,000  ga~ for 1.5 h (SW40 
rotor, Beckman Instruments, Palo Alto, CA), The fraction that was visual- 
ized as a single band one-third up the density gradient was recovered and 
kept on ice until  time of assay. 
Cell-Free Assay  for Degradation of  Insulin within 
Isolated Endosomes 
Endosomes containing 5-20 ng t2Sl-insulin.mg  cell fraction protein  -I were 
suspended in a  cell-free system after recovery from the density gradient 
(final  concentrations:  40-50-pg  cell  fraction  protein.ml  -t  in  20  mM 
Hepes, pH 7.4,  250  mM sucrose,  150  mM KCI, 5  mM NaCI,  15  mM 
MgCI2,  1 mM DTT,  10 mM ATP.K2). Samples were incubated at 37°C for 
varying lengths of time after which the integrity of internalized tesI-insulin 
was assessed by ptecipitability in ice cold 10%  TCA. 
To determine the pH optimum of endosomal degradation, isolated endo- 
somes were suspended in the cell-free system (minus ATP) buffered with 
25 mM potassium acetate, Hepes, or imidazole to pH 3-8. Nigericin (10 
#M) and valinomycin (10 pM) were included to equilibrate endosomal pH 
with that of the buffers and samples were incubated for 30 min after which 
degradation of ~2Sl-insulin was assessed by acid solubility of radiolabel. 
Extraction of  Radioactivity from Isolated Endosomes 
Rats were injected via the portal vein with 2 #g t25I-insulin/100  g  (body 
weight) and 5 rain later, animals were sacrificed, and the GE fraction iso- 
lated. Isolated endosomes were suspended in the cell-free system for either 
0 rain (4°C) or 15 rain (37°C) after which, 1 M acetic acid and 0.1% Triton 
X-100 were added to samples on ice. Samples were centrifuged at  110,000 
gay (TL  100.2,  Beckman Instruments) for 30 rain,  and the supernatants 
were decanted carefully and frozen. By this method, > 96% of the radioac- 
tivity was extractable. Thawed samples were chromatographed on Sephadex 
G-50 columns (1.2 × 55-cm) and eluted with 1 M acetic acid. Radioactivity 
within endosomes containing internalized 12SI-EGF was acid extracted as 
above and chromatographed on similar columns. Samples which eluted at 
the positions of intact 1251-insulin or  12SI-EGF (the peak of radioactivity 
and one sample on either side of the peak) were pooled, neutralized, and 
assessed for specific binding to liver plasma membranes at 4°C for 14 h as 
described previously (56). 
Cell-Free  Acidification Assay 
ATP-dependent acidification was assayed as described by Glickman et al. 
(38) with minor modifications. The GE fraction harvested from the density 
gradient was slowly diluted in assay buffer (final concentration, 10 tzg cell- 
fraction protein.ml  -I, 2  mM Hepes, 2  mM Tris, pH 7.0, 150 mM KCi, 
6 mM MgCI2,  1 mM DTT) and pelleted at 16,000 gay for 1 h (60Ti  rotor, 
Beckman Instruments). The pellet was then gently resuspended in the same 
buffer with three strokes of a  Dounce homogenizer (Wheaton Scientific, 
Millville, NJ) using a type B pestle and equilibrated in buffer for 3-6 h at 
4°C. Acridine orange was then added to the membranes to a final concentra- 
tion of 6 pM. ATP was added (final concentration 0.4 mM) and acidification 
monitored by recording the change in the absorption spectrum of acridine 
orange  as  it  concentrated within  acidic  compartments.  The  absorption 
difference at 492 and 540 nm was recorded with a dual wavelength spec- 
trophotometer (Aminco DW-2;  American Instrument Co., Silver Spring, 
MD),  kindly provided by Dr.  J.  G.  Joly (H6pital  Saint-Luc,  Montreal, 
Canada). 
Polyethylene  Glycol Precipitation (PEG) of 
Insulin-Receptor Complexes 
GE fractions were suspended in the cell-free degradation assay system for 
0  and  15  min  5:  ATP  in the presence or absence of 1 mM p-chloro- 
mecuribenzoic acid (PCMB).  Subsequently, samples containing ,050 ~g 
cell fraction protein were suspended in HMT buffer (20 mM Hepes, pH 7.4, 
i0 mM MgCl2, 0.1% Triton X-100) for 10 rain after which PEG 8,000 and 
rabbit gamma globulins were added to final  concentrations of 10%  and 
2 mg.ml  -t , respectively. The precipitate was pelleted (2,000 gay, 45 min, 
IEC, DPR 6,000),  the supernatant decanted carefully,  and both the pellet 
and supernatant counted for radioactivity in a Compugamma counter (1285; 
LKB Instruments, Inc., Gaithersburg, MD; 65%  efficiency). 
Electron Microscopy  of  GE Fractions 
GE fractions were suspended in the cell-free system for either 0 rain (4°C) 
or 30 rain (37°C) and subsequently were fixed on ice with 2.5% glutaralde- 
hyde, 100 mM sodium cacodylate, pH 7.4. Aliquots containing "030/~g cell 
fraction protein were filtered onto nitrocellulose filters (Millipore Corpora- 
tion, MA) using a filtration apparatus (5). Samples were then postfixed in 
2 % OsO4 in 100 mM sodium cacodylate, pH 7.4 for 2 h at 4°C, and stained 
en bloc with 1% tannic acid in 100 mM sodium cacodylate (pH 7.0) (66), 
and 8% uranyl acetate in 100 mM maleic buffer (pH 5.0) (44), and subse- 
quently processed for routine microscopy. 
Results 
Internalization and Cell-Free  Degradation of  Insulin 
in Intact Endosomes 
At 5 rain after the injection of low levels of insulin (100 ng/ 
100 g bw) hormone was concentrated maximally within en- 
dosomes of  the GE fraction isolated from liver homogenates. 
[~2q]-Insulin was 40 +  4-(mean +  SD, n  =  9) fold enriched 
in the fraction as compared to the parent homogenate. This 
5-min internalization period has been shown previously to 
result in the entry of insulin into endosomes but not lyso- 
somes (12, 57). 
The cell-free system described by Diment and Stahl (26) 
was  used to evaluate the degradation of internalized ~25I- 
insulin within endosomes of the GE fraction (Fig. 1). Degra- 
dation of 12q-insulin was rapid between 0 and 15 min of in- 
cubation at 37°C (t~ of initial velocity, 6 min) and reached 
a plateau by 60 min of incubation with 71  5= 5 % of the inter- 
nalized hormone degraded. Inclusion of an ATP regenerat- 
ing system into the cell-free system (20 mM creatine phos- 
phate, 5 IU creatine phosphokinase) or further addition of 
Mg2+-ATP at  15  and 30 min of incubation resulted in no 
further increase in the concentration of insulin degraded over 
time (not shown). Sephadex G-50 chromatography (Fig. 2) 
of radioactivity extracted from endosomes of the GE fraction 
isolated from rats given a higher insulin dose (2 pg '2q-in- 
sulin/100 g bw) showed a threefold increase in the size of the 
peak eluting at the position of radioiodotyrosine (peak III) 
after 15 min of incubation in the cell-free system. Radio- 
activity eluting at the position of intact  J25I-insulin (peak 
II) was evaluated for specific binding to liver plasma mem- 
branes. At 0 min and 15 min of incubation, specific binding 
of extracted radioactivity eluting in peak II was 28 and 31%/ 
50 pg cell fraction protein, respectively. Negligible binding 
to liver plasma membranes was observed for material eluting 
in peaks I or III (specific binding, 0.6 and 0.5 %,  respec- 
tively). 
The selectivity of endosomal degradation was assessed by 
incubating endosomes of the GE fraction containing inter- 
nalized  ~25I-EGF or  '2q-prolactin  in  the  cell-free system. 
Degradation of ~2q-EGF within isolated endosomes was not 
detectable by acid precipitation (Fig.  1) or Sephadex G-50 
chromatography (Fig. 2). Radioactivity extracted from endo- 
somes at 0 min and 15 min of incubation that eluted as intact 
'25I-EGF (peak IV) showed specific binding to liver plasma 
membranes  of  11  and  10%/50  /~g  cell  fraction protein, 
respectively (not shown).  No degradation of ~2q-prolactin 
within isolated endosomes was observed as evaluated by acid 
precipitation (Fig.  1). Hence, only insulin was degraded to 
acid soluble constituents in the cell-free system. Endosomal 
degradation of internalized  ~2q-insulin followed apparent 
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Figure 1.  Selective degradation of internalized  ~25I-insulin within 
isolated intact endosomes. Endosomes containing internalized ~251- 
insulin  (e), ~25I-EGF (A) or ~25I-prolactin (B) were suspended and 
maintained in the cell-free system for the indicated times. The in- 
tegrity of each ligand was assessed by precipitability of radiolabel 
in cold  10% TCA (mean  :1: SD, n  =  3). 
Michaelis-Menten  kinetics with an apparent V.~ of 4  ng in- 
sulin degraded-min-l.mg  cell  fraction protein -~ and appar- 
ent Km of 60 ng insulin-mg cell fraction protein -= (Fig.  3). 
Structural integrity of endosomes during incubation in the 
cell-free system was evaluated by electron microscopy. The 
freshly prepared GE fraction (Fig. 4 A) consisted of a hetero- 
geneous mix of elements of the Golgi apparatus and endo- 
somes filled with their characteristic content of lipoprotein- 
like particles.  Little difference in morphology was observed 
after incubation  for 30 min at 37°C  in the cell-free system 
(Fig.  4  B). 
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Figure 2. Chromatography of radioactivity extracted from GE frac- 
tion. Radiolabel was acid extracted from GE fractions containing 
internalized insulin  (A and B) or ~25I-EGF (C and D) at 0 rain (A 
and C) or 15 min (B and D) of incubation in the cell-free system 
and analyzed by Sephadex G-50 chromatography. The void volume 
of the  column  (peak I)  and  the  elution  positions  of intact  ~2~I- 
insulin (peak II), 125I-tyrosine (peak IlI), and intact 125I-EGF (peak 
IV) are indicated. 
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Figure 3. In vivo dose-response of endosomai insulin degradation. 
Rats were injected  via the portal vein with increasing doses of ~25I- 
insulin  (0.05-20  ttg/100  g  bw) to internalize  increasing concen- 
trations of insulin  within endosomes. Isolated GE fractions were 
suspended in the cell-free system and the reciprocal of the initial 
velocity of insulin  degradation (l/V0,  ng degraded.rain -I .mg cell 
fraction protein -~) was assessed as a function of the reciprocal of 
the  concentration  of insulin  within endosomes  (l/S,  ng.mg cell 
fraction protein-~). 
Effect of Protease Inhibitors and Detergent on 
Endosomal Degradation  of Insulin 
To characterize the endosomal insulin-specific degrading ac- 
tivity, we included various protease inhibitors in the cell-free 
system and assessed  their effect on  '25I-insulin degradation 
(Table  I).  Addition  of ieupeptin,  pepstatin,  aprotinin,  an- 
tipain,  PMSE  or  EDTA  had  no  significant  effect on  '25I- 
insulin  degradation.  However,  both  PCMB  and  1,10- 
phenanthroline  inhibited  degradation  by  100  and  91%, 
respectively. Inclusion of bacitracin into the cell-free system 
resulted in a 40 % inhibition of degradation.  Significant inhi- 
bition of degradation  was also observed after disruption  of 
isolated endosomes  with 0.1%  Triton  X-100. 
ATP-dependent Acidification  of Endosomes Is 
Required for Maximal Degradation  of Insulin 
Diment and Stahl (26) reported that degradation of mannose- 
BSA within isolated macrophage endosomes was dependent 
on the presence of ATP during  in vitro incubation.  There- 
fore,  we  examined  the  nucleotide  requirements  for  the 
insulin-degrading  activity  present  within  isolated  endo- 
somes.  Maximal  degrading  activity  was  found  when  ATP 
was  included  in the cell-free system (Table II).  Significant 
but lower activity was found in the absence of ATE This was 
not likely because of endogenous ATP since inclusion of an 
ATP-depleting system (glucose  +  hexokinase) produced no 
significant  reduction  in  '25I-insulin  degradation.  Substitu- 
tion  of ATP  with  AMP.PNP,  ADP,  GTP,  or  a  mixture of 
ADP  and  GTP  to  promote  ATP  formation  by  a  possible 
nucleoside diphosphokinase did not result in a restoration of 
maximal insulin  degrading  activity observed with  ATE 
To test  whether  the effect of ATP on  endosomal  insulin 
degradation  was  mediated  through  activation  of  the  en- 
dosomal  proton  translocase  and  consequent  endosomal 
acidification,  we included various pH dissipating agents and 
proton translocase inhibitors into the cell-free system and as- 
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t2Sl-lnsulin Degradation  in Endosomes 
t2Sl-insulin degraded 
Addition  Concentration  (percentage  of control) 
Protease inhibitors 
None  100 
Leupeptin  10 ttg.mi  -~  99.1  4- 4.2* 
Pepstatin  10/zg.ml  -~  98.9  4- 5.7* 
Aprotinin  10/~g-ml  -z  99.1  4- 2.9* 
Antipain  10/zg-ml  -t  83.1  +  19.1" 
PMSF  1 mM  89.2  +  13.5" 
PCMB  1 mM  0  +  0.9* 
EDTA  I  mM  99.6  +  1.9" 
1,10-Phenanthroline  1 mM  8.8  4- 0.4~: 
Bacitracin  5  mg-ml  -t  60.5  +  3.9~ 
(62,000  U.ml  -a) 
Detergent 
Triton X-100  0.1%  22.9  4- 4.8* 
Degradation  of endocytosed m251-insulin  was assessed in isolated GE fractions 
incubated in the cell-free system in the presence of the indicated compounds. 
Degradation  was determined by acid solubility of radiolabel  at 30 min of in 
vitro incubation.  Results are expressed as a percent of ~2Sl-insulin  degradation 
observed  in  the  standard  ceil-free system as  described  in  Materials  and 
Methods. All observations are means of three separate experiments 5: SD with 
significance evaluated  by t test. 
* Not significant. 
* P ~  0.0001. 
Figure 4. Electron microscopy of endosome fractions. (A) At 0  min 
of incubation in the cell-free system, both stacked saccules of the 
Golgi apparatus (G) and intact endosomes (En)  with their charac- 
teristic content of lipoprotein-like particles (lp) are observed. Con- 
tamination of the fraction by other organelles is negligible. (B) Af- 
ter  a  30-rain  incubation  at  37°C  in  the  cell-free  system,  the 
structural  integrity  of both endosomes and  Golgi  apparatus  was 
maintained  with no evidence of organelle aggregation or fusion. 
Bar,  0.5  #m. 
sessed their effects on insulin degradation. Inclusion of the 
proton ionophores nigericin and monensin, or the weak base 
chloroquine inhibited degradation by "~80 %. Addition of the 
potassium ionophore, valinomycin, also inhibited degrada- 
tion,  but only by  17%.  Addition of N-ethylmaleimide and 
dicyclohexylcarbodiimide  at concentrations known to inhibit 
the endosomal proton pump (51) resulted in significant inhi- 
bition of degradation, while addition of oligomycin, the in- 
hibitor of the mitochondrial proton pump (51), vanadate, an 
ATPase  inhibitor  which  is  thought  not  to  affect the  en- 
dosomal proton pump (51) or amiloride, the inhibitor of the 
Na+/H+-antiporter  (62),  had  little  effect  on  degradation. 
Table II. ATP-dependent Acidification of  lsolated Intact 
Endosomes Is Required for Maximal Insulin Degradation 
~2Sl-insulin degraded 
Addition  Concentration  (percentage  of control) 
Nucleotides 
ATP 
None 
None  +  glucose  + 
hexokinase 
AMP- PNP 
ADP 
GTP 
ADP  +  GTP 
Ionophores 
Nigericin 
Monensin 
Valinomycin 
Weak base 
Chioroquine 
Proton pump inhibitors 
NEM 
DCCD 
Oligomycin 
Vanadate 
Amiloride 
10  mM  100 
35.4  4- 4.2* 
5  mM  +  10  U.ml  -~  31.9  4- 0.2* 
10 mM  24.5  -1- 6.2* 
10 mM  40.0  4- 2.9* 
10 mM  52.8  4- 4.2~ 
10 mM (each)  26.2  4-  1.6' 
50 #M  17.4  4- 0.9* 
50/~M  20.6  +  4.1, 
50 #M  83.3  4- 2.8§ 
2  mM  16.3  +  1.1~ 
10  p,M  23.6  4- 4.5* 
1 mM  26.8  +  2.6* 
10 #M  50.4  :i:  14.611 
l  mM  38.7  +  2.2* 
5  /zg.ml  -~  90.2  4- 4.81 
100/~M  99.9  4- 2.9* 
2  mM  96.6  4-  3.7* 
Endosomal  degradation  of ~2~I-insulin observed between 0  and 30 min of in 
vitro incubation after the addition of the indicated compounds is expressed as 
a percent of the degradation  observed in the standard cell-free system (mean 
+  SD, n  =  3). Significance was evaluated by t test. NEM, N-ethylmaleimide; 
DCCD, dicyclohexylcarbodiimide. 
* Not significant. 
* P  ~  0.0001. 
§ P  ~  0.001. 
II P  <  0.005. 
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ATP-dependent acidification of the GE fraction. The ink 
tial rates of quenching of acridine orange absorbance as the dye 
concentrated within acidic components was monitored as a function 
of cell fraction protein. At the end of the incubations, 1 #M nigeri- 
cin (N) was added to the system to dissipate the generated pH gra- 
dients. The inset shows representative tracings at doses of 30, 60, 
and  120 #g cell fraction protein assayed (mean +  half variation, 
n  =  2). 
These results suggested that lowering of the endosomal pH 
through proton translocase activity was required for maxi- 
mal activity of the insulin protease(s). 
We tested directly the ATP-dependent proton translocase 
activity of the GE fraction using the method of Glickman et 
al. (38) (Fig. 5). After addition of ATP, components of the 
GE fraction acidified with an initial rate that was dependent 
on the concentration of cell fraction protein (Fig. 5 and in- 
set). The pH gradients generated through proton translocase 
activity were dissipated rapidly after addition of nigericin to 
the cell-free system. Acridine orange absorption levels were 
restored above initial baseline levels after addition of nigeri- 
cin (Fig. 5, inset). 
The effect of pH on endosomal degradation of insulin was 
tested by incubating endosomes containing internalized =2~I- 
insulin in the cell-free system buffered to pH 3-8 minus ATP. 
Before assay,  both nigericin and valinomycin (10 #M) were 
included in the cell-free system to dissipate any endogenous 
endosomal pH gradients. Optimal degradation was observed 
at a pH of 5.5  (Fig. 6). 
Relationship between Insulin Dissociation 
and Degradation 
Attempts  were  made  to  evaluate  the  effect of endosomal 
acidification on the amount of receptor bound insulin in en- 
dosomes by PEG precipitation of insulin-receptor complexes 
(23,  25).  Comparison of the proportion of acid and PEG 
precipitable ~25I-insulin indicated that freshly prepared en- 
dosomes retained 82% intact '25I-insulin of which 41% was 
receptor-bound (see Fig. 7 legend). After a  15-rain  incuba- 
tion,  the  dissociation  of  1.7  ng  insulin-rag  cell  fraction 
protein  -~ was observed although the degradation of insulin 
was  5.8 rig-rag  cell fraction protein  -~  (Fig.  7,  B).  Incuba- 
tions carried out minus ATP resulted in no loss of receptor- 
bound insulin. However, the loss and degradation of free in- 
sulin was 2.1  ng.mg cell fraction protein  -j  (Fig.  7,  C).  In 
parallel experiments (not shown), prolactin dissociation was 
evaluated. Before incubation, 60% of internalized prolactin 
was dissociated from its receptor. After 15 min of incubation 
in the cell-free system, the proportion of dissociated prolac- 
tin remained similar (i.e., 50%). Furthermore, no degrada- 
tion of prolactin occurred during the incubation (see Fig. 1). 
In a separate study, Lai et al. (49a) have observed that 43 % 
of EGF was dissociated in freshly prepared endosomes. 
We next determined the effect of ATP on ligand dissocia- 
tion  under  conditions  where  insulin  degradation  was  in- 
hibited by PCMB (Fig. 7, D and E) or 1,10 phenanthroline 
(not shown). With both inhibitors, degradation in the pres- 
ence or absence of  ATP was inhibited as was insulin dissocia- 
tion. Hence, any further dissociation of insulin required con- 
tinued insulin degradation. 
Discussion 
The endosomal apparatus consists of a series of heteroge- 
neous and distinct, nonlysosomal, endocytic components in- 
volved in the sequential uptake and sorting of internalized 
ligands and their receptors (10,  13,  14, 41, 42, 52, 58). We 
have studied endosomes isolated from liver homogenates for 
their capacity to degrade internalized insulin, EGF, and pro- 
lactin. The particular fraction employed was designated the 
GE fraction based on the presence of both elements of the 
Golgi apparatus and lipoprotein-filled endosomes in the frac- 
tion (Fig. 4). This fraction has been characterized previously 
for its content of marker enzymes (9), cytochemistry (67), 
and by EM radioautography for ligand uptake (46). More re- 
cently, the lipoprotein content of endosomes in the GE frac- 
tion has been confirmed by immunolabeling (Ahluwalia, J., 
L. Germain, B. I. Posner, and J. J. M. Bergeron, manuscript 
in preparation). 
We have concluded that endosomes in this fraction de- 
graded internalized insulin, but neither EGF nor prolactin, 
to acid soluble products. The cell-free system that was used 
maintained the structural  integrity of isolated endosomes. 
The initial velocity of degradation was rapid, and identical 
to the in vivo rate of insulin clearance as observed in prior 
studies (t~, 6 min) (12).  However, the extent of degradation 
was not complete. As the further addition of ATP at 15 or 
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Figure 6. pH dependency of insulin degradation in GE fractions. 
GE fractions containing 6 ng insulin.mg  cell fraction protein  -~ 
were suspended in the cell-free system (minus ATP) buffered with 
potassium acetate, Hepes, or imidazole (25 mM) at various pHs 
ranging from 3 to 8. Nigericin (10 #M) and valinomycin (10 #M) 
were included to equilibrate endosomal pH with that of the buffer. 
Degradation of ~2~l-insulin was assessed after 30 min of incubation 
by acid solubility of radiolabel (mean  +  SD, n  =  3). Maximal 
degradation was observed at pH 5.5 and normalized to 100%. 
Doherty et al. Insulin Degradation in Endosomes  39 15 
~a. 
=  .O 
_=u.  6 
3 
0 
0  15 +ATP  15 -ATP  15 +ATP  15 -ATP 
*PCMB  +PCMB 
Time (rain) 
Figure 7. Insulin degradation and dissociation.  Intact (open bars) 
and receptor-bound  (closed bars) insulin within endosomes  were 
determined at 0 min (A) and 15-min incubation in the cell-free sys- 
tem +  ATP (B and C) as well as in cell-free incubations carried 
out in the presence of 1 mM PCMB  +  ATP (D and E). Freshly 
isolated endosomes (0 min) contained  12 ng insulin-mg cell frac- 
tion protein -~ (mean -I- SD, n =  3) as calculated from the propor- 
tion of acid precipitable radiolabel (82 %) and the specific radioac- 
tivity of ~2Sl-insulin. The proportion of receptor bound ligand was 
determined  by PEG precipitation  as described  in Materials  and 
Methods. The content of intact and receptor bound insulin after 15 
min of incubation of endosomes of the GE fraction +  ATP was de- 
termined by the same methods.  Significant loss of intact insulin 
(open bars) occurred  after  15-min incubation  +ATP  (B,  P  ~< 
0.0005) or -ATP (C, P ~< 0.05). However, the amount of insulin 
that  was receptor-bouod  (closed bars) was significantly lowered 
(P ~< 0.0005) in incubations  +ATP (B) but not for those  -ATP 
(C). Addition of PCMB resulted in no significant loss of intact insu- 
lin (open bars, D and E) or of receptor-bound insulin (closed bars, 
D and E) for incubations in the presence or absence of ATP. Identi- 
cal results to those indicated in D and E were found when ceil-free 
incubations were carried out with endosomes incubated at pH 5.5 
in potassium acetate buffer in the presence of 10 ttM valinomycin 
and  10/~M nigericin (data not shown). 
30 min of incubation or inclusion of an ATP regenerating 
system had no effect on ligand degradation then the limited 
extent of degradation observed likely reflects the lability of 
the endosomal insulin proteolytic activity in vitro. 
Based on the  assays employed (i.e.,  acid  precipitability 
and Sephadex G-50 chromatography), we were unable to de- 
tect degradation of EGF or prolactin.  The possibility that 
these ligands may be in endosomal components distinct to 
those  internalizing  insulin  was  considered  unlikely.  Prior 
studies have shown that at 5-min postinjection, insulin (45), 
EGF (34), and prolactin were localized within the same en- 
dosomes as those harboring internalized asialoglycoprotein. 
A  rapid  and  subtle  processing  of EGF occurring  most 
probably in endosomes has been documented in fibroblasts 
by several groups (50,  54, 63, 69).  These processing steps 
appear limited to the removal of 6 amino acids from the car- 
boxy terminal region by three proteolytic events (50, 54, 63). 
Carpenter et al. (20,  21) have shown that the binding affinity 
of des 48-53 EGF is 10% that of the native molecule. Since 
no difference was observed in the binding to liver plasma 
membranes of extracted  ':SI-EGF at 0 and  15 min of incu- 
bation, it would appear that this carboxyl terminal process- 
ing of EGF was not occurring within endosomes of the GE 
fraction  under  our incubation  conditions.  The absence of 
EGF proteolytic activity within isolated endosomes may be 
attributed to disparities between hepatic and fibroblast endo- 
somes, or possibly, the absence of endosomal components 
containing this activity in the GE fraction. 
Diment and Stahl (26) have previously demonstrated en- 
dosomal degradation of mannose-BSA internalized via the 
mannose receptor of macrophages. With  an identical cell- 
free system to that employed here, Diment and Stahl (26) ob- 
served inhibition of degradation by leupeptin, pepstatin, an- 
tipain,  and PMSF  and have identified a  membrane bound 
cathepsin  D  in macrophage endosomes as responsible for 
proteolysis of internalized mannose-BSA (27).  By contrast, 
we found no effect of leupeptin, pepstatin, antipain, PMSF, 
aprotinin,  or EDTA on  insulin  degradation  in  liver endo- 
somes. The sensitivity of endosomal insulin degradation to 
PCMB, 1,10 phenanthroline, and bacitracin as well as the in- 
sensitivity of leupeptin, pepstatin,  aprotinin,  antipain,  and 
PMSF is similar to the characteristics of a cytosolic insulin 
degrading enzyme recently cloned (1). The cytosolic local- 
ization of this insulin degrading enzyme (64, 65) and its near 
neutral pH optimum (29, 30) suggest that a distinct but related 
enzyme may be located within hepatic endosomes. 
Electron  microscopy  demonstrated  that  endosomes  re- 
mained intact during the cell-free incubations. Indeed, inclu- 
sion of 0.1% Triton X-100 in the cell-free system resulted in 
significant inhibition of degradation. This was also observed 
by Diment and Stahl (26) for degradation of mannose-BSA 
within macrophage endosomes. The observation likely is ex- 
plained by a dissipation of the endosomal pH gradient (vide 
infra) and also serves to rule out any contaminating  lyso- 
somes as responsible for the insulin degrading activity ob- 
served in vitro. 
The observation that ATP was required for maximal insu- 
lin degradation prompted us to examine whether endosomal 
acidification  through  proton  translocase  activity  was  re- 
quired for optimal degrading activity. The GE fraction was 
highly active in ATP dependent acridine orange uptake (Fig. 
5).  The fraction,  however,  is  heterogeneous  consisting of 
Golgi saccules and lipoprotein-filled endosomes.  Although 
acidotropic agents have been shown to accumulate in trans 
Golgi components (for review, see reference 4), we suggest 
that the ATP-dependent acridine orange uptake of the GE 
fraction was mainly because of endosomes. Both the pH op- 
tima of Golgi apparatus sugar transferase activities (11, 18) 
and the lack of fusion activity of the influenza hemagglutinin 
precursor HAO (16) during biosynthetic traverse of the Golgi 
apparatus  indicate  that  Golgi  compartments are  not  very 
acidic (16). In this context, the contribution of contaminating 
endosomes in the Golgi fraction of Glickman et al. (38) for 
proton translocase activity had not previously been evaluated. 
The inhibition of insulin degradation observed after inclu- 
sion of proton ionophores, the weak base chloroquine,  and 
proton  translocase  inhibitors  in  the  cell-free  system sup- 
ported our conclusion that degradation was regulated by the 
proton  translocating  activity  of endosomes.  A  small but 
significant  inhibitory  effect  of  the  potassium  ionophore 
valinomycin was observed; this effect was likely because of 
an increase in endosomal [K  ÷] that may inhibit the maximal 
extent of proton translocation. 
The demonstration of optimal insulin degrading activity at 
pH 5.5  (Fig. 6) also supported the contention that degrada- 
tion  was  regulated  by  endosomal  acidification.  However, 
even at pH 7.4, 22 % of maximal degradation was observed. 
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clusion of nigericin, monensin, or chloroquine into the cell- 
free system. However, under the standard incubation condi- 
tions, when endosomal pH was not equilibrated with that of 
the cell-free system, insulin degradation in the absence of 
ATP was higher than the expected 22 %; i.e., 35 % of control 
(Table II). We suggest that this 13% difference may be be- 
cause of degradation occurring within a population of endo- 
somes that were acidified in vivo and retained their protons 
during isolation and in vitro incubation. 
The PEG precipitation studies demonstrated that in freshly 
prepared  endosomes,  the majority of internalized insulin 
(59%) was dissociated from receptor. That this represented 
maximal insulin dissociation was shown by the inclusion of 
PCMB into the cell-free system (Fig. 7, D); no further dis- 
sociation was observed in the presence of ATP. Only when 
degradation proceeded maximally (+ATP) was net insulin 
dissociation observed (Fig.  7,  B).  Hence, despite the de- 
crease in pH expected after adding ATP or by incubating en- 
dosomes at pH 5.5 (see Fig. 7 legend) no further effect on 
Ko was observed.  As explained elsewhere (6,  10),  the ex- 
tent of ligand dissociation is expected to be limited by the 
small volume of endosomes (,'~10  -~7 liters) and by the high 
intraluminal concentration of free insulin that would quickly 
counteract pH induced changes in Ko. By coupling degra- 
dation and dissociation in the endosome, rapid and complete 
removal of internalized receptor-bound insulin may therefore 
be expected. The observations on incubations carried out 
-ATP (Fig. 7, C) were noteworthy. Here, insulin degradation 
occurred with no loss of receptor-bound insulin observed. 
Thus, free insulin was serving as the preferred substrate for 
the insulin degrading activity. 
A number of the reported sites of proteolytic cleavage of 
insulin (31-33) occur in the receptor binding domain of insu- 
lin  (24).  Dissociation of insulin from its  receptor would 
facilitate availability of these sites to the endosomal pro- 
tease(s).  However,  selective  degradation  of  internalized 
ligands within the isolated endosomes was not a consequence 
of selective dissociation as 60%  of prolactin and 43%  of 
EGF were dissociated from receptor in freshly isolated en- 
dosomes. Analysis of the primary sequences of  porcine insu- 
lin (15), ovine prolactin (36), and mouse EGF (20, 60) and 
knowledge of the sites of cleavage of insulin in liver (31-33) 
show seven  potential sites for prolactin processing but no 
analogous sites for EGE Selectivity of endosomal process- 
ing may be a consequence of secondary and tertiary struc- 
tural differences between insulin and prolactin that enable in- 
ternalized insulin, but not prolactin, to serve as substrate for 
the endosomal protease(s). 
The observations presented here extend our past studies 
(12,  14, 40, 56) and those of Pease et al. (53) and resolve 
several previously puzzling observations. These include (a) 
the extraordinarily rapid kinetics of insulin clearance from 
liver as opposed to prolactin and EGF (61); (b) the selective 
effect of  chloroquine in accumulating internalized insulin but 
not prolactin in subcellular fractions enriched in endosomes 
(12, 47, 57); (c) the identification of insulin fragments in en- 
dosomes corresponding to the in vivo sites of insulin cleavage 
(40); and (d) the inability to document extensive entry of in- 
sulin into acid phosphatase enriched lysosomes (7,  12, 57). 
For liver,  insulin degrading activity has been reported at 
the cell surface (70) in lysosomes (22) and in the cytosol (64, 
65). These studies may indicate sites of proteolytic activity 
that are unavailable for interacting with the majority of cell- 
associated insulin under physiological conditions. 
The demonstration of insulin proteolytic activity in endo- 
somes  extends  the  work  of  several  groups  who  have 
documented proteolytic activity and specific proteases  in 
components of the endosomal apparatus (2, 26, 27, 37, 40, 
53, 59, 63, 69). The significance of endosomal processing of 
internalized ligands remains speculative. Several interpreta- 
tions propose a model of lysosomal maturation involving a 
biogenetic pathway of newly synthesized lysosomal proteases 
through endosomal components (19, 37, 59).  However,  the 
targeting of insulin specific proteases to endosomes may be 
of physiological significance. Insulin is rapidly degraded in 
vivo by two processes. A nonselective, nonreceptor mediated 
high capacity pathway via the proximal convoluted tubule of 
the kidney (8) that ensures rapid clearance of insulin from 
the circulation (35) and a selective receptor mediated path- 
way in the liver. The liver parencbymal cell is the first major 
target organ to interact with insulin from the pancreas and 
is responsible for degrading the majority of incoming insulin 
(29,  30).  After initial binding to hepatic surface receptors, 
insulin activates receptor tyrosine kinase activity and the 
receptor is rapidly internalized (39, 48). As isolated liver en- 
dosomes harbor activated insulin receptor kinase after inter- 
nalization (48, 49), insulin dissociation and degradation con- 
sequent to endosomal acidification may limit the extent and 
duration of insulin receptor kinase activity and thereby en- 
sure rapid termination of the insulin response in liver. 
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